Poisoning + STOPP-START Flashcards

1
Q

What is pharmacological toxicity?

A
  • Extension of pharmacological action at a known site
  • most often a predictable extension to desired effect
  • or secondary effect
  • or due to a higher dose than prescribed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is biochemical toxicity?

A

A drug or active metabolites which cause cellular damage - proteins + enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the uses of atropine as an antidote?

A

Treating nerve agent + organophosphate poisoning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Management of drug overdose

A
  • immediate actions
  • supportive measures
  • enhanced elimination
  • antidotes
  • prevention of absorption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is STOPP-START?

A

Screen Tool of Older People’s Prescriptions
Screening Tool to Alert to Right Treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the aim of STOPP-START?

A

Highlight + prevent inappropriate prescribing > reduction in DDIs + ADRs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What patient group is STOPP-START validated for?

A

Patients 65 and over

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When might it be appropriate to remove/replace a drug on a patient’s prescription?

A
  • no clear evidence of benefit
  • risk of bleeding
  • risk of toxicity
  • side effects.
  • condition has improved or stabilised
  • DDIs/safety concerns
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Management of drug overdose in relation to immediate action

A
  • remove person from contact with poison
  • vital signs + injury
  • history
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Management of drug overdose in relation to prevention of absorption

A
  • activated charcoal: large absorbent area given as suspension in water
  • not suitable for drowsy or comatose patients
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why is gastric lavage (stomach pumping) almost never used in prevention of absorption during overdose management?

A

Risk of aspiration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Management of drug overdose in relation to elimination

A
  • continued activated charcoal
  • sodium bicarbonate: alkaline diuresis in salicylate poisoning
  • haemodialysis
  • forced diuresis is not recommended > serious electrolyte imbalance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How can atropine be used in the treatment of organophosphate poisoning?

A
  • cholinergic muscarinic competitive antagonist
  • blocks acetylcholine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Management of drug overdose in relation to antidotes

A
  • competitive antagonists: e.g. naloxone, atropine
  • chelating agents: form complex with poison > reducing free drug e.g. cyanide, lead, iron salts
  • manipulating drug metabolism: e.g. fomepizole, acetylcysteine
  • antivenoms
  • digoxin specific antibody
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How do chelating agents work as antidotes of drug overdose?
Examples

A

Forms complex with poison > reduces free drug
e.g. cyanide, lead, iron salts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When can haemodialyisis be used in Managment of drug overdose?

A

If drug has small Vd
Only in seriously ill patients

17
Q

How is fomepizole used in overdoses?

A
  • inhibits alcohol dehydrogenase
  • can be used in antifreeze + alcohol poisoning
18
Q

What pharmacokinetic + dynamic changes in older people should be considered?

A
  • body composition: increased fat, decreased body water + lean mass
  • reduced renal mass + function
  • hepatic function + blood flow
  • GI absorption + bleed risk
  • reduced first pass metabolism
19
Q

What should be thought about during a drug review?

A
  • is medication right for patient?
  • time limited medications
  • age
  • is medication effective
  • cost
  • appropriate tests to support decisions
  • ADRs + DDIs
20
Q

What groups of patients should be particular targeted from a drug review?

A
  • elderly
  • co-morbidities
  • out-patients
  • high risk meds
  • frequent admissions to hosptial
  • meds prescribed from lots of sources